Atlas Trials

Paraproteinemias

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Paraproteinemias

RecordFirmDate
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor (NCT05298683)Hellenic Society of Hematology2022-05-01
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible (NCT05280275)Hellenic Society of Hematology2022-04-13
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment (NCT05147493)Hellenic Society of Hematology2022-04-01
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma (NCT04309084)Celularity Incorporated2020-05-12
Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma (NCT02155634)Celgene2014-07-01
Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging (NCT02462213)University of Cincinnati2013-10-01
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings (NCT01755000)Washington University School of Medicine2012-12-01
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT00001287)National Institute of Neurological Disorders and Stroke (NINDS)1990-12-01

Track Paraproteinemias automatically

Every clearance here is in the API, with alerts when new ones post.